Imatinib Tablets Ip 400 Mg contains the active ingredient imatinib mesylate. This works by inhibiting the activity of specific tyrosine kinases, including BCR-ABL, c-KIT, and PDGF-R, which are involved in the abnormal growth and proliferation of cancer cells. Imatinib is a tyrosine kinase inhibitor used in the treatment of various cancers, including chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs), and certain types of acute lymphoblastic leukemia (ALL). By blocking these kinases, imatinib helps to inhibit the growth of cancer cells and induce their death. Imatinib Tablets Ip 400 Mg works by inhibiting the activity of specific tyrosine kinases, including BCR-ABL, c-KIT, and PDGF-R, which are involved in the abnormal growth and proliferation of cancer cells.
Specification
|
Brand |
Imatib |
|
Dose/Strength |
400 mg |
|
Packaging Type |
Stripe |
|
Shelf Life |
24 MONTH |
|
Usage/Application |
Hospital |

Price:
Price 5000 INR / Box
Minimum Order Quantity : 100 Boxes
Storage : Dry Place
Usage : Hospital
Grade : Pharma
Appearance : Tablets
Price 800 INR / Box
Minimum Order Quantity : 100 Strips
Storage : Dry Place
Usage : Hospital
Grade : Pharma
Appearance : Tablets
Price 10000 INR / Box
Minimum Order Quantity : 100 Packs
Storage : Dry Place
Usage : Hospital
Grade : Pharma
Appearance : Tablets
Price 10000 INR / Box
Minimum Order Quantity : 100 Bottles
Storage : Dry Place
Usage : Hospital
Grade : Pharma
Appearance : Tablets